Search

A gene previously linked to autism spectrum disorder (ASD) by UT Southwestern Medical Center researchers appears to play an important role in steering cells in the brain’s hippocampus toward their ultimate identities, the same team reported in a new study. The findings, published in Science Advances, could eventually lead to new therapies for the prevalent neurodevelopmental disorder.

Measuring blood pressure while patients are standing rather than sitting may improve the accuracy of readings, UT Southwestern Medical Center researchers report.

Electronic Health Record vendors in the $31.5 billion industry should not be permitted to provide continuing medical education activities and presentations to physicians to avoid bias, researchers argue in a perspective article for the Association of American Medical Colleges’ journal, Academic Medicine.

An RNA-modifying enzyme linked to cancer and neurological disorders selects its targets by recognizing specific RNA shapes and sequences, according to a study by UT Southwestern Medical Center researchers.

UT Southwestern Medical Center researchers have discovered a key molecular mechanism that allows animals to adapt to changing environmental conditions without altering their genes – an ability known as phenotypic plasticity.

Wachsmann Assists in "Rewriting the cancer story" Published on: July 27, 2026 Dr. Megan Wachsmann Rewriting the cancer story Back-to top

Researchers at UT Southwestern have uncovered evidence that the higher prevalence of “malignant” enlargement of the heart among blacks contributes to the higher incidence of heart failure in this population.

Interpreting relatively inexpensive electrocardiograms (ECGs) with an artificial intelligence (AI) algorithm accurately screened patients for a key precursor of heart failure in Kenya, a study led by UT Southwestern Medical Center researchers shows.

While Black and Hispanic families are enthusiastic about research participation, other provider and systems-focused factors may influence their involvement in pediatric oncology clinical trials, a new UT Southwestern Medical Center-led study has found.

An experimental antibody treatment that binds to a protein known as PCDH7 shrank tumors in preclinical models of non-small cell lung cancer (NSCLC), even those resistant to a targeted therapy, a study led by UT Southwestern Medical Center researchers showed.